Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Wanbury Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
524212
INE107F01022
6.7020953
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
WANBURY
31.46
840.96
EPS(TTM)
Face Value(
)
Div & Yield %:
8.16
10
0
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
575.65
499.65
511.19
392.52
367.45
391.37
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
575.65
499.65
511.19
392.52
367.45
391.37
Other Income
2.99
0.91
77.88
2.40
83.78
9.33
Stock Adjustments
3.89
-29.13
24.79
7.20
-5.99
5.06
Total Income
582.53
471.43
613.86
402.12
445.24
405.76
EXPENDITURE :
Raw Materials
306.52
274.31
325.07
228.53
169.75
201.26
Power & Fuel Cost
24.58
20.59
18.41
17.13
15.38
14.46
Employee Cost
86.92
81.00
74.81
64.15
67.48
75.89
Other Manufacturing Expenses
13.32
11.43
12.66
9.98
13.77
7.98
Selling & Administrative Expenses
58.51
45.16
55.34
45.49
55.36
63.70
Miscellaneous Expenses
19.69
15.45
14.36
16.42
16.29
17.59
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
509.54
447.94
500.65
381.70
338.02
380.89
Operating Profit
72.99
23.49
113.19
20.42
107.23
24.86
Interest
29.18
21.39
20.61
23.07
32.87
39.88
Gross Profit
43.81
2.10
92.58
-2.65
74.36
-15.02
Depreciation
13.03
12.38
11.45
9.75
9.68
9.97
Profit Before Tax
30.78
-10.28
81.13
-12.40
64.68
-24.99
Tax
0.00
0.00
0.00
2.27
0.00
0.00
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
0.38
0.11
-0.35
-2.07
0.21
-0.14
Reported Net Profit
30.40
-10.40
81.47
-12.61
64.46
-24.85
Extraordinary Items
0.49
-0.31
76.06
1.21
82.62
0.12
Adjusted Net Profit
29.91
-10.09
5.41
-13.82
-18.16
-24.97
Adjustment below Net Profit
-0.59
0.26
0.80
-0.44
-0.46
0.31
P & L Balance brought forward
-168.14
-158.01
-240.28
-227.23
-291.23
-266.69
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
P & L Balance carried down
-138.34
-168.14
-158.01
-240.28
-227.23
-291.23
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
0.00
0.00
0.00
0.00
0.00
0.00
Dividend Per Share(Rs)
0.00
0.00
0.00
0.00
0.00
0.00
Earnings Per Share-Unit Curr
9.28
-3.18
24.94
-5.04
25.79
-10.48
Earnings Per Share(Adj)-Unit Curr
9.28
-3.18
24.94
-5.04
25.79
-10.48
Book Value-Unit Curr
6.70
-2.26
0.57
-52.23
-47.14
-77.40
Book Value(Adj)-Unit Curr
6.70
-2.26
0.57
-52.23
-47.14
-77.40